Johnson & Johnson (JNJ) director receives 975 deferred share units in Form 4 filing

Rhea-AI Filing Summary

Beckerle Mary C reported acquisition or exercise transactions in this Form 4 filing.

Johnson & Johnson director Mary C. Beckerle received 975 Deferred Share Units (DSUs) as a grant under the company’s Amended and Restated Deferred Fee Plan for Directors. After this award, she holds a total of 16,797.7393 DSUs. These DSUs will be settled in cash upon the end of her board service, with each DSU reflecting the fair market value of one J&J common share on the settlement date. The position also includes dividend equivalent rights that accrue on DSUs in line with Johnson & Johnson’s quarterly dividends.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Beckerle Mary C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units	975	$0.00	--

Holdings After Transaction: Deferred Share Units — 16,797.739 shares (Direct, null)

Footnotes (1)

1. Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Key Figures

Deferred Share Units granted: 975 units Total DSUs after grant: 16,797.7393 units Transaction price per DSU: $0.0000 per unit +1 more

4 metrics

Deferred Share Units granted 975 units Grant to director Mary C. Beckerle on April 23, 2026

Total DSUs after grant 16,797.7393 units Mary C. Beckerle’s Deferred Share Units holding following transaction

Transaction price per DSU $0.0000 per unit Grant/award acquisition under director deferred fee plan

Underlying common stock 975 shares reference Each DSU corresponds to the value of one J&J common share

Key Terms

Deferred Share Units, Amended and Restated Deferred Fee Plan for Directors, dividend equivalent rights, fair market value

4 terms

Deferred Share Units financial

"Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors"

Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.

Amended and Restated Deferred Fee Plan for Directors financial

"acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors"

dividend equivalent rights financial

"Includes dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

fair market value financial

"each DSU representing the fair market value of one share of Common Stock on the settlement date"

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beckerle Mary C

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NEW JERSEY 08933

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	04/23/2026		A		975		(1)	(1)	Common Stock	975	$0	16,797.7393(2)	D

Explanation of Responses:

1. Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).

2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Mary C. Beckerle	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Johnson & Johnson (JNJ) disclose about Mary C. Beckerle’s latest Form 4?

Johnson & Johnson reported that director Mary C. Beckerle received 975 Deferred Share Units as a grant under the company’s director fee plan. Following this award, she now holds 16,797.7393 DSUs, which are designed to track the value of J&J common stock and settle in cash.

How many Deferred Share Units did JNJ director Mary C. Beckerle receive?

Mary C. Beckerle was granted 975 Deferred Share Units in this Form 4 filing. These units are part of Johnson & Johnson’s Amended and Restated Deferred Fee Plan for Directors and are tied to the fair market value of J&J common stock on the future settlement date.

What is Mary C. Beckerle’s total Deferred Share Unit balance at Johnson & Johnson (JNJ)?

After the latest grant, Mary C. Beckerle holds a total of 16,797.7393 Deferred Share Units. This balance includes the newly awarded 975 DSUs plus previously accumulated units, all of which are linked to Johnson & Johnson’s common stock value at eventual cash settlement.

How are Mary C. Beckerle’s Deferred Share Units at JNJ settled and valued?

Her Deferred Share Units are settled in cash when her directorship ends. Each DSU represents the fair market value of one Johnson & Johnson common share on the settlement date, so the eventual cash amount depends on the stock’s market price at that time.

Do Johnson & Johnson Deferred Share Units include dividend equivalents for Mary C. Beckerle?

Yes, her Deferred Share Units include dividend equivalent rights. These rights accrue in connection with Johnson & Johnson’s quarterly dividend on DSUs she holds, effectively mirroring the economic benefit of dividends paid on the company’s common stock over time.